Jupiter Neurosciences, Inc. (JUNS) stock
JUNSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.52−0.18 (-10.59%)
Close on Nov 17, 2026Market cap $1.17MP/E –Yield –
Jupiter Neurosciences total assets
Total assets on the balance sheet at the end of each period.
Jupiter Neurosciences's total assets was $3.72M at Jun 30, 2026. For fiscal 2025 it was $5.56M, down 10.3% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.56M | -10.3% |
| FY2024 | Dec 31, 2024 | $6.20M | +4074.1% |
| FY2023 | Dec 31, 2023 | $148.59K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $3.72M | -6.3% |
| Q1 FY2026 | Mar 31, 2026 | $3.95M | -20.4% |
| Q4 FY2025 | Dec 31, 2025 | $5.56M | -10.3% |
| Q3 FY2025 | Sep 30, 2025 | $2.58M | +2911.5% |
| Q2 FY2025 | Jun 30, 2025 | $3.97M | +2570.5% |
| Q1 FY2025 | Mar 31, 2025 | $4.96M | – |
| Q4 FY2024 | Dec 31, 2024 | $6.20M | – |
| Q3 FY2024 | Sep 30, 2024 | $85.55K | – |
| Q4 FY2023 | Dec 31, 2023 | $148.59K | – |
See a number that looks wrong?